glp-1 drug comparison Medication vs. Bariatric Surgery for Weight Loss: Options Matter Free Energy Is Toujeo a GLP-1? The

What once represented a specialized class of diabetes treatments has grown into one of the most consequential therapeutic categories in modern medicine, with GLP-1 receptor agonists now fundamentally restructuring how obesity, metabolic disease and potentially even neurodegeneration are treated

Aung MM, et al

The companies will initially commence four development programs for potential small-molecule therapies directed to one or more select GPCR targets, including GLP-1, GIP, and glucagon receptors

After years of trying to lose weight "the right way," Jane Zuckerman realized that "putting in the work just wasn't enough." Zuckerman, a 32-year-old data analyst based in Washington, D.C., said she lost 90 pounds in college and spent years cycling through nutritionists, therapy and strict routines only to find herself at her heaviest after the pandemic, at 270 pounds